Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease
Journal of Clinical Lipidology · 2025
DOI: 10.1016/j.jacl.2025.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Byung Jin Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Kor…. Hauptthemen laut MEDLINE: Lipoprotein(a), Coronary Vessels, Calcium, Atherosclerosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A combined evaluation of the associations of lipoprotein(a) (LP[a]) and coronary artery calcium score (CACS) with atherosclerotic cardiovascular disease (ASCVD) has not been conducted in the Asian population. OBJECTIVE: We explored whether elevated LP(a) levels and CACS are independently and jointly associated with ASCVD. METHODS: This cross-sectional study included 44,354 participants (mean age 40.6 years, 72.8% male) from the Kangbuk Samsung Health Study, conducted between March 2010 and December 2019, who were tested for LP(a) and CACS. High LP(a) was defined as LP(a) ≥120 nmol/L, and CACS categories were divided as CACS = 0 vs CACS > 0. ASCVD was identified as physician-diagnosed or -treated angina pectoris, myocardial infarction, or ischemic stroke. RESULTS: The prevalence of high LP(a), CACS >0, and ASCVD was 11.9%, 15.7%, and 1.1%, respectively. Multivariable regression analyses indicated that high LP(a) and CACS >0 were independently associated with prevalent ASCVD (odds ratio [95% CI], 1.36 [1.02, 1.81] and 1.79 [1.40, 2.30], respectively). Compared with individuals with low LP(a)/CACS = 0, those with high LP(a)/CACS > 0 had the highest odds ratio for ASCVD (2.40 [1.58, 3.63]), as did those with low LP(a)/CACS > 0 (1.79 [1.38, 2.33]). However, high LP(a)/CACS = 0 did not significantly increase the odds ratio for ASCVD (1.36 [0.90, 2.05]). CONCLUSION: High LP(a) levels and the presence of CAC are independently associated with ASCVD. Given that both markers were additively associated with ASCVD when elevated, more aggressive management to reduce cardiovascular risk may be warranted. Longitudinal studies are necessary to clarify the combined causal relationship between these 2 markers and cardiovascular events in the Asian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea (Dr Kim). Electronic address: bjjake.kim@samsung.com.
- Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea (Dr Kang); Department of Clinical Research Design & Evaluation, SAIHST,…
Zitieren
APA
Kim, B. J., & Kang, J. (2025). Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.02.007
Vancouver
Kim BJ, Kang J. Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.02.007
BibTeX
@article{Kim2025,
author = {Kim, Byung Jin and Kang, Jeonggyu},
title = {Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease},
journal = {Journal of Clinical Lipidology},
year = {2025},
doi = {10.1016/j.jacl.2025.02.007}
}
EUVIMED